The U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, endoscopic retrograde cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. The largest segment in the total GI endoscopic device market was the GI flexible endoscope segment. This segment represented approximately 24.5% of the total market in 2016. The relatively large size of this segment is due to a combination of relatively high average selling price (ASP) coupled with relatively short life-span of five years, resulting in constant renewal of the equipment. One of the main drivers in this market is the growth in the procedure numbers, such as colonoscopy and therapeutic ERCP. Colonoscopy has become a gold-standard in the colorectal cancer screening program, with more than 18 million procedures performed annually. A lot of devices discussed in this report are used in conjunction with the each other, thus having a multiplication effect on the size of the market with each extra procedure performed.
The full report suite on the U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, eEndoscopic Retrograde retrograde Cholangiopancreatography cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. There are several on-going trends in the GI space such as the expansion of the therapeutic capabilities of the devices fueled by the market desire for the less-invasive treatment options. For example, the stenting and dilation devices that are now used for patients that would have had to undergo surgical intervention in the past. The other emerging trend is related to challenges with the infection control for the GI devices that now are making inroads for growing popularity of the single-use devices, even on the originally capital equipment type of devices such as scopes.
'
TABLE OF CONTENTS I
LIST OF FIGURES V
LIST OF CHARTS VII
EXECUTIVE SUMMARY 1
U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 6
MARKET DEVELOPMENTS 8
PROCEDURE NUMBERS 9
PROCEDURE CODES INVESTIGATED 10
MARKETS INCLUDED 11
1.1 KEY REPORT UPDATES 15
VERSION HISTORY 15
RESEARCH METHODOLOGY 16
1.1 RESEARCH SCOPE 16
1.2 IDATA’S 9-STEP METHODOLOGY 16
Step 1: Project Initiation & Team Selection 16
Step 2: Prepare Data Systems and Perform Secondary Research 18
Step 3: Preparation for Interviews & Questionnaire Design 19
Step 4: Performing Primary Research 20
Step 5: Research Analysis: Establishing Baseline Estimates 22
Step 6: Market Forecast and Analysis 23
Step 7: Identify Strategic Opportunities 25
Step 8: Final Review and Market Release 26
Step 9: Customer Feedback and Market Monitoring 27
DISEASE OVERVIEW 28
2.1 BASIC ANATOMY 28
2.2 GASTROINTESTINAL DISEASE: TREATMENT AND DIAGNOSTICS 29
2.2.1 Gastro-Esophageal Reflux Disease (GERD) 32
2.2.2 Barrett's Esophagus 33
2.2.3 Digestive Cancer 33
2.2.4 Gastrointestinal bleeding 35
2.2.5 Bile Duct Disorders 36
2.2.6 Crohn’s disease 37
2.2.7 Ulcer 37
2.2.8 Ogilvie Syndrome or Intestinal Pseudo-Obstruction 38
2.3 PATIENT DEMOGRAPHICS 40
2.3.11 Patient Demographics 40
2.3.11.1 All Digestive Diseases 40
2.3.11.2 Abdominal Wall Hernia 42
2.3.11.3 Chronic Constipation 42
2.3.11.4 Diverticular Disease 42
2.3.11.5 Prescriptions 42
2.3.11.6 Gastroesophageal Reflux Disease 43
2.3.11.7 Gastrointestinal Infections 43
2.3.11.8 Hemorrhoids 43
2.3.11.9 Inflammatory Bowel Disease 44
2.3.11.10 Liver Disease 44
2.3.11.11 Pancreatitis 45
2.3.11.12 Peptic Ulcer Diseases 45
2.3.12 Digestive Cancer 46
U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW 49
3.1 MARKET OVERVIEW 49
3.2 TREND ANALYSIS 55
3.3 DRIVERS AND LIMITERS 59
3.3.1 Market Drivers 59
3.3.2 Market Limiters 60
3.4 COMPETITIVE MARKET SHARE ANALYSIS 62
3.5 COMPANY PROFILES 70
3.5.1 Boston Scientific Corporation 70
3.5.2 Olympus 71
3.5.3 Medtronic 72
3.5.4 Cook Medical 74
3.5.5 Halyard Health 75
3.5.6 HOYA Group Pentax Medical 75
3.5.7 Fujifilm Holdings Corporation 76
3.5.8 US Endoscopy 78
3.5.9 CONMED Corporation 79
3.5.10 C. R. Bard 80
3.5.11 ERBE USA Inc. 81
3.5.12 EndoGastric Solutions 81
3.5.13 General Electric 81
3.6 SWOT ANALYSIS 83
3.6.1 Boston Scientific 83
3.6.2 Olympus 84
3.6.3 Medtronic 85
3.6.4 Cook Medical 86
3.6.5 Halyard 87
3.7 MERGERS AND ACQUISITIONS 88
3.7.1 Olympus 88
3.7.2 Boston Scientific Corporation 89
3.7.3 Medtronic 91
3.7.4 HOYA Group Pentax Medical 93
3.7.5 Fujifilm Holdings Corporation 94
3.7.7 Abbott Nutrition 95
3.7.8 US Endoscopy 96
3.7.10 CONMED Corporation 97
3.7.12 Halyard Health 98
3.7.14 Ethicon, Johnson & Johnson and others 99
3.7.16 Medivators, a Cantel Medical Company 100
3.7.17 EndoChoice Holdings, Inc. 101
3.7.18 Vital Images and Toshiba 102
ABBREVIATIONS 103
Chart 1 1: Gastrointestinal Endoscopic Device Market by Segment, U.S., 2013 – 2023 2
Chart 1 2: Gastrointestinal Endoscopic Device Market Overview, U.S., 2016 & 2023 2
Chart 2 1: Male Incidence, Digestive Cancer, U.S., 2016 47
Chart 2 2: Male Deaths, Digestive Cancer, U.S., 2016 47
Chart 2 3: Female Incidence, Digestive Cancer, U.S., 2016 48
Chart 2 4: Female Deaths, Digestive Cancer, U.S., 2016 48
Chart 3 1: Gastrointestinal Endoscopic Device Market by Segment, U.S., 2013 – 2023 53
Chart 3 2: Gastrointestinal Endoscopic Device Market Breakdown, U.S., 2016 54
Chart 3 3: Gastrointestinal Endoscopic Device Market Breakdown, U.S., 2023 54
Chart 3 4: Growth Rates by Segment, Gastrointestinal Endoscopic Device Market, U.S., 2013 – 2023 58
Chart 3 5: Leading Competitors, Gastrointestinal Endoscopic Device Market, U.S., 2016 69
Figure 1 1: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (1 of 2) 4
Figure 1 2: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (2 of 2) 4
Figure 1 3: Companies Researched in this Report, U.S., 2016 5
Figure 1 4: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (1 of 2) 6
Figure 1 5: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (2 of 2) 7
Figure 1 6: Recent Events in the Gastrointestinal Endoscopic Device Market, U.S., 2012 – 2016 8
Figure 1 7: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 9
Figure 1 8: Procedure Codes Investigated, U.S., 2016 10
Figure 1 9: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (1 of 4) 11
Figure 1 10: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (2 of 4) 12
Figure 1 11: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (3 of 4) 13
Figure 1 12: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (4 of 4) 14
Figure 1 13: Key Report Updates 15
Figure 1 14: Version History 15
Figure 2 1: Leading Physician Diagnoses for GI Disorders, U.S., 2009 31
Figure 2 2: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (1 of 2) 40
Figure 2 3: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (2 of 2) 41
Figure 2 4: Digestive Cancer Statistics by Type and Gender, U.S., 2016 46
Figure 3 1: Total Gastrointestinal Endoscopic Device Market by Segment, U.S., 2013 – 2023 (US$M) 50
Figure 3 2: Gastrointestinal Endoscopic Device Market by Segment, U.S., 2013 – 2023 (US$M) (1 of 2) 51
Figure 3 3: Gastrointestinal Endoscopic Device Market by Segment, U.S., 2013 – 2023 (US$M) (2 of 2) 52
Figure 3 4: Gastrointestinal Endoscopic Device Market Growth Rates by Segment, U.S., 2013 – 2023 (1 of 2) 56
Figure 3 5: Gastrointestinal Endoscopic Device Market Growth Ratesby Segment, U.S., 2013 – 2023 (2 of 2) 57
Figure 3 6: Drivers and Limiters, Gastrointestinal Endoscopic Device Market, U.S., 2016 61
Figure 3 7: Leading Competitors, Gastrointestinal Endoscopic Device Market, U.S., 2016 (1 of 2) 67
Figure 3 8: Leading Competitors, Gastrointestinal Endoscopic Device Market, U.S., 2016 (2 of 2) 68
Figure 3 9: SWOT Analysis, Boston Scientific, 2016 83
Figure 3 10: SWOT Analysis, Olympus, 2016 84
Figure 3 11: SWOT Analysis, Medtronic, 2016 85
Figure 3 12: SWOT Analysis, Cook Medical, 2016 86
Figure 3 13: SWOT Analysis, Halyard, 2016 87
Boston Scientific
Olympus
Medtronic
Cook Medical
Halyard
Medline
Pentax
ConMed
Fujinon
Moog
C. R. Bard
Endogastric
GE Healthcare
Others include: Alcor Scientific, Applied Medical Technologies, BARD, C2 Therapeutics, Capso Vision, ConMed, CSA Medical, Endochoice, ERBE, Genii, GI Supply, Hobbs Medical, Intromedic, Mederi, Medigus, Medivators, Medline, Merit Endotek, Micro-tech Endoscopy, Mobile Instruments, Moog, Northfield Instruments, Philips, Prezio, MedService International, Rendoscopy, Siemens, Steris, Taewoon Medical, Telemed Systems, TeraREcon, Torax, US Endoscopy, Viatronix, Vital Images, and others.
